当前位置:首页 >财报库 > 报告详情

嘉德诺Cardinal Health(CAH)2025财年10-K年度报告「NYSE」(英文版)(111页).pdf

上传人: 1****1 编号:923998 2025-09-25 111页 1.47MB

下载:

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-KANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended June 30,2025orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1

2、934For the transition period from _ to _Commission File Number:1-11373Cardinal Health,Inc.(Exact name of registrant as specified in its charter)Ohio31-0958666(State or other jurisdiction ofincorporation or organization)(IRS EmployerIdentification No.)7000 Cardinal PlaceDublin,Ohio43017(Address of pr

3、incipal executive offices)(Zip Code)(614)757-5000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon shares(without par value)CAHNew York Stock ExchangeSecuriti

4、es registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No oIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the A

5、ct.Yes o No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 duringthe preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject t

6、o such filing requirements forthe past 90 days.Yes No oIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter peri

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
- **公司概况**:Cardinal Health是一家全球医疗保健服务和产品公司,为医院、医疗保健系统、药房等提供定制化解决方案。 - **财务状况**:2025财年,收入为2226亿美元,同比下降2%;GAAP运营利润为23亿美元,同比增长83%;非GAAP运营利润为28亿美元,同比增长15%。 - **主要业务**:分为药品和特殊解决方案(Pharma)和全球医疗产品与分销(GMPD)两大业务板块。 - **收购活动**:2025财年,公司进行了多起收购,包括Advanced Diabetes Supply Group (ADS)、GI Alliance (GIA) 和 Integrated Oncology Network (ION)。 - **市场风险**:美国对某些国家商品征收的关税可能对公司成本和财务状况产生负面影响。 - **其他重要事项**:公司预计2026财年资本支出约为6亿美元,主要用于制造和分销基础设施项目和技术投资。
业绩如何?" ** "卡戴尔2025年财报揭示了哪些关键增长点?" 新战略成效如何?" ** "卡戴尔通过收购和战略调整,2025年业绩有何变化?"
客服
商务合作
小程序
服务号
折叠